Evolent Health, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Evolent Health, Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00.
- Evolent Health, Inc. payments for repurchase of common stock for the quarter ending 2024-12-31 was $0.00.
- Evolent Health, Inc. payments for repurchase of common stock for fiscal 2025 was $40.00M.
- Evolent Health, Inc. payments for repurchase of common stock for fiscal 2024 was $0.00.
- Evolent Health, Inc. payments for repurchase of common stock for fiscal 2023 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $40.00M 10-K · filed 2026-02-25 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |